- Home
- ITOS vs DOMO Comparison
ITOS vs DOMO Comparison
Compare ITOS & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- DOMO
- Stock Information
- Founded
- ITOS 2011
- DOMO 2010
- Country
- ITOS United States
- DOMO United States
- Employees
- ITOS N/A
- DOMO N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- DOMO Computer Software: Prepackaged Software
- Sector
- ITOS Health Care
- DOMO Technology
- Exchange
- ITOS Nasdaq
- DOMO Nasdaq
- Market Cap
- ITOS 342.6M
- DOMO 286.1M
- IPO Year
- ITOS 2020
- DOMO 2018
- Fundamental
- Price
- ITOS $8.32
- DOMO $9.45
- Analyst Decision
- ITOS Strong Buy
- DOMO Hold
- Analyst Count
- ITOS 3
- DOMO 5
- Target Price
- ITOS $33.67
- DOMO $9.60
- AVG Volume (30 Days)
- ITOS 543.4K
- DOMO 229.7K
- Earning Date
- ITOS 11-12-2024
- DOMO 12-05-2024
- Dividend Yield
- ITOS N/A
- DOMO N/A
- EPS Growth
- ITOS N/A
- DOMO N/A
- EPS
- ITOS N/A
- DOMO N/A
- Revenue
- ITOS $35,000,000.00
- DOMO $318,369,000.00
- Revenue This Year
- ITOS $271.18
- DOMO $0.39
- Revenue Next Year
- ITOS N/A
- DOMO N/A
- P/E Ratio
- ITOS N/A
- DOMO N/A
- Revenue Growth
- ITOS N/A
- DOMO 0.19
- 52 Week Low
- ITOS $7.54
- DOMO $6.11
- 52 Week High
- ITOS $18.75
- DOMO $12.23
- Technical
- Relative Strength Index (RSI)
- ITOS 39.51
- DOMO 68.26
- Support Level
- ITOS $7.54
- DOMO $8.31
- Resistance Level
- ITOS $8.38
- DOMO $9.26
- Average True Range (ATR)
- ITOS 0.53
- DOMO 0.37
- MACD
- ITOS 0.01
- DOMO 0.02
- Stochastic Oscillator
- ITOS 35.94
- DOMO 86.79
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.